Patents by Inventor Eleonora Kiss

Eleonora Kiss has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230130598
    Abstract: The present invention relates to a compound of formula (I) or a stereoisomer, or tautomer, (I) wherein A1, A2, R1 and R2, have the same meaning as that defined in the claims and the description. The present invention also relates to compositions, in particular pharmaceuticals, comprising such compounds, and to uses of such compounds and compositions for the prevention and/or treatment of an infection caused by pestivirus in an animal.
    Type: Application
    Filed: February 24, 2021
    Publication date: April 27, 2023
    Applicant: KATHOLIEKE UNIVERSITEIT LEUVEN
    Inventors: Eleonora KISS, Robert VRANCKEN, Nesya GORIS
  • Patent number: 9040699
    Abstract: The present invention relates to the preparation of cyclopropane derivatives, in particular 2-amino-9-[[(1S,2R)-1,2-bis(hydroxymethyl)cyclopropyl]methyl]-4,8-dihydro-1H-purin-6-one, especially via the [(1S,7R)-4-phenyl-3,5-dioxabicyclo[5.1.0]octan-1-yl]methanol intermediate.
    Type: Grant
    Filed: November 10, 2011
    Date of Patent: May 26, 2015
    Assignee: Aratana Therapeutics NV
    Inventors: Eleonora Kiss, Erwin Blomsma, Serge De Bruijn, E. J. N. Remy Litjens
  • Publication number: 20150051394
    Abstract: The present invention relates to the preparation of cyclopropane derivatives, in particular 2-amino-9-[[(1S,2R)-1,2-bis(hydroxymethyl)cyclopropyl]methyl]-4,8-dihydro-1H-purin-6-one, especially via the [(1S,7R)-4-phenyl-3,5-dioxabicyclo[5.1.0]octan-1-yl]methanol intermediate.
    Type: Application
    Filed: November 10, 2011
    Publication date: February 19, 2015
    Applicant: ARATANA THERAPEUTICS NV
    Inventors: Eleonora Kiss, Erwin Blomsma, Serge De Bruijn, E.J.N. Remy Litjens
  • Publication number: 20150018427
    Abstract: The present invention relates to compounds for use in a method for the treatment or prevention of parvovirus infections in humans and warm-blooded animals, including feline panleukopenia virus (FPV) infections in felids, canine parvovirus type 2 (CPV-2) infections in canines, minute virus of mice (MVM) infections in mice and B19 parvovirus infections in humans.
    Type: Application
    Filed: February 22, 2013
    Publication date: January 15, 2015
    Applicant: Aratana Therapeutics NV
    Inventors: Nesya Goris, Johan Neyts, Erwin Blomsma, Stefaan Wera, Jérôme Villers, Ainola Billiet, Joeri Auwerx, Veerle Debeurme, Eleonora Kiss, Chloë Swinnen